Fosamax
NDC 54868-3857
Product Information
Fosamax is a NDA-approved product labeled by Physicians Total Care, Inc.. Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. It is supplied as a white product. This product entry covers the primary NDC 54868-3857 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
OVAL (C48345)
11 MM
MRK;925
MRK;936
Code Structure Chart
Product Details
What is NDC 54868-3857?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ALENDRONATE SODIUM (UNII: 2UY4M2U3RA)
- ALENDRONIC ACID (UNII: X1J18R4W8P) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CARNAUBA WAX (UNII: R12CBM0EIZ)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 904396 - alendronate sodium 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG Oral Tablet
- RxCUI: 904396 - alendronic acid 35 MG (as alendronate sodium 45.7 MG) Oral Tablet
- RxCUI: 904399 - FOSAMAX 35 MG Oral Tablet
- RxCUI: 904399 - alendronic acid 35 MG Oral Tablet [Fosamax]
* Please review the full disclaimer at the bottom of this page.